Back
Consolidated Edison 10K Form
Sell
39
ED
Consolidated Edison
Last Price:
$89.51
Seasonality Move:
1.44%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-02 | 10Q | ED/Consolidated Edison Quarterly |
2024-02-15 | 10K | ED/Consolidated Edison Annual |
2023-11-02 | 10Q | ED/Consolidated Edison Quarterly |
2023-08-03 | 10Q | ED/Consolidated Edison Quarterly |
2023-05-04 | 10Q | ED/Consolidated Edison Quarterly |
2023-02-16 | 10K | ED/Consolidated Edison Annual |
Receive ED News And Ratings
See the #1 stock for the next 7 days that we like better than ED
ED Financial Statistics
Sales & Book Value
Annual Sales: | $14.7B |
---|---|
Cash Flow: | $-745M |
Price / Cash Flow: | 0 |
Annual Sales: | $63.29 |
Price / Book: | 1.42 |
Profitability
EPS (TTM): | 5.32000 |
---|---|
Net Income (TTM): | $1.8B |
Gross Margin: | $7.4B |
Return on Equity: | 8.59% |
Return on Assets: | 2.76% |
Consolidated Edison Earnings Forecast
Key Consolidated Edison Financial Ratios
-
The Gross Profit Margin over the past 30 years for ED is 50.50%.
-
The Selling, General & Administrative Expenses for ED have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 40.61% of Operating Income.
-
The Net Earning history of ED is 17.18% of Total Revenues.
-
Per Share Earnings over the last 40 years have been positive in 24 years.
Consolidated Edison Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Multi-Utilities |
Sector: | Utilities |
Current Symbol: | ED |
CUSIP: | 209115 |
Website: | conedison.com |
Debt
Debt-to-Equity Ratio: | 1.18 |
---|---|
Current Ratio: | 1.01 |
Quick Ratio: | 0.61 |
Price-to-Earnings
Trailing P/E Ratio: | 12.44 |
---|---|
Forward P/E Ratio: | 15.93 |
ED Technical Analysis vs Fundamental Analysis
Sell
39
Consolidated Edison (ED)
is a Sell
Is Consolidated Edison a Buy or a Sell?
-
Consolidated Edison stock is rated a SellThe current Consolidated Edison [ED] share price is $89.67. The Score for ED is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.